ヘルスケアCMO (ヘルスケア受託製造機関)とは、法的な契約に基づき、医薬品の開発や製造などの包括的なサービスを一定期間提供する企業です。世界のヘルスケアCMO市場は、2023年に1,458億3,000万ドルと評価され、2029年には2,912億5,000万ドルに成長すると予測されます。
ヘルスケアCMO市場は、主に慢性疾患の有病率の上昇と世界人口の高齢化に拍車をかけた医薬品およびバイオ医薬品の需要の増加により、長年にわたって大幅な成長を遂げてきました。また、製薬会社がCMOに製造をアウトソーシングし、コスト削減やコアコンピタンスへの注力を図る動きも、市場拡大に大きく貢献しています。製造技術とプロセスの進歩により、CMOは高品質でスケーラブルで費用対効果の高い生産ソリューションを提供できるようになりました。その他の重要な動向には、AI技術の役割の増大、個別化医療、持続可能性とグリーン製造、高度な製造技術、細胞および遺伝子治療の拡大などがあります。世界のヘルスケアCMO市場は、2024年から2029年の予測期間にわたって12.22%のCAGRで成長する見込みです。
目次
Table of Contents
1. Executive Summary
2. Introduction
2.1 Healthcare Contract Manufacturing Organization (CMO): An Overview
2.1.1 Benefits Of Healthcare CMOs
2.2 Healthcare CMO Segmentation: An Overview
2.2.1 Healthcare CMO Segmentation
3. Global Market Analysis
3.1 Global Healthcare CMO Market: An Analysis
3.1.1 Global Healthcare CMO Market: An Overview
3.1.2 Global Healthcare CMO Market by Value
3.1.3 Global Healthcare CMO Market by Type (Pharmaceutical and Medical Device)
3.1.4 Global Healthcare CMO Market by Region (North America, Europe, Asia Pacific, and rest of the World (ROW)
3.2 Global Healthcare CMO Market: Type Analysis
3.2.1 Global Healthcare CMO Market by Type: An Overview
3.2.2 Global Pharmaceutical CMO Market by Value
3.2.3 Global Pharmaceutical CMO Market by Service (Active Pharmaceutical Ingredients (API) and Others)
3.2.4 Global Medical Devices CMO Market by Value
3.3 Global Pharmaceutical CMO Market: Service Analysis
3.3.1 Global Pharmaceutical CMO Market by Service: An Overview
3.3.2 Global Active Pharmaceutical Ingredients (API) CMO Market by Value
3.3.3 Global Other Pharmaceuticals CMO Market by Value
4. Regional Market Analysis
4.1 North America Healthcare CMO Market: An Analysis
4.1.1 North America Healthcare CMO Market: An Overview
4.1.2 North America Healthcare CMO Market by Value
4.1.3 North America Healthcare CMO Market by Region (The US, Canada and Mexico)
4.1.4 The US Healthcare CMO Market by Value
4.1.5 The US Healthcare CMO Market by Type (Pharmaceutical and Medical Device)
4.1.6 The US Pharmaceutical Healthcare CMO Market by Value
4.1.7 The US Medical Devices Healthcare CMO Market by Value
4.1.8 Canada Healthcare CMO Market by Value
4.1.9 Mexico Healthcare CMO Market by Value
4.2 Europe Healthcare CMO Market: An Analysis
4.2.1 Europe Healthcare CMO Market: An Overview
4.2.2 Europe Healthcare CMO Market by Value
4.2.3 Europe Healthcare CMO Market by Region (Germany, The UK, France, Italy, Spain, and Rest of the Europe)
4.2.4 Germany Healthcare CMO Market by Value
4.2.5 The UK Healthcare CMO Market by Value
4.2.6 France Healthcare CMO Market by Value
4.2.7 Italy Healthcare CMO Market by Value
4.2.8 Spain Healthcare CMO Market by Value
4.2.9 Rest of Europe Healthcare CMO Market by Value
4.3 Asia Pacific Healthcare CMO Market: An Analysis
4.3.1 Asia Pacific Healthcare CMO Market: An Overview
4.3.2 Asia Pacific Healthcare CMO Market by Value
4.3.3 Asia Pacific Healthcare CMO Market by Region (China, Japan, India, South Korea, and Rest of the Asia Pacific)
4.3.4 China Healthcare CMO Market by Value
4.3.5 Japan Healthcare CMO Market by Value
4.3.6 India Healthcare CMO Market by Value
4.3.7 South Korea Healthcare CMO Market by Value
4.3.8 Rest of Asia Pacific Healthcare CMO Market by Value
4.4 Rest of World Healthcare CMO Market: An Analysis
4.4.1 Rest of World Healthcare CMO Market: An Overview
4.4.2 Rest of World Healthcare CMO Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19 on Global Healthcare CMO Market
5.2 Surge in Contracts to CDMOs
5.3 Post-COVID Scenario
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Surging Geriatric Population
6.1.2 Rising Healthcare Expenditure
6.1.3 Increasing Spread of Chronic Diseases
6.1.4 Escalating Demand for Generic Drugs
6.1.5 Cost Efficiency
6.1.6 Complexity of Biologics Manufacturing
6.1.7 Increasing Demand for Active Pharmaceutical Ingredient (API)
6.2 Challenges
6.2.1 Regulatory Compliance
6.2.2 Dependent on Patents, Copyrights, Trademarks and Trade Secrets
6.3 Market Trends
6.3.1 Escalating Role of Artificial Intelligence Technology
6.3.2 Personalized Medicine
6.3.3 Sustainability and Green Manufacturing
6.3.4 Advanced Manufacturing Technologies
6.3.5 Expansion in Cell and Gene Therapy
6.3.6 Exploration of Alternative Expression Systems
6.3.7 Growing Inclination Towards Herbal Products
7. Competitive Landscape
7.1 Global Healthcare CMO Market: Competitive Landscape
7.2 Global Healthcare CMO Market Players: Financial Comparison
8. Company Profiles
8.1 Catalent Pharma Solutions Inc.
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Samsung Biologics Co. Ltd.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy
8.3 Aurobindo Pharma Limited
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Boehringher Ingelheim
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy
8.5 Integer Holdings Corporation
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Piramal Pharma Limited
8.6.1 Business Overview
8.6.2 Net Revenue by Business Verticals
8.6.3 Business Strategy
8.7 Lonza Group AG
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy
8.8 Thermo Fisher Scientific Inc.
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy
8.9 Recipharm AB
8.9.1 Business Overview
8.9.2 Business Strategy
8.10 Fareva Group
8.10.1 Business Overview
8.10.2 Business Strategy
8.11 Symbiosis Pharmaceutical Services
8.11.1 Business Overview
8.11.2 Business Strategy
8.12 Cytovance Biologics
8.12.1 Business Overview
8.12.2 Business Strategy
8.13 Curia
8.13.1 Business Overview
8.13.2 Business Strategy
List of Figures
Figure 1: Benefits Of Healthcare CMOs
Figure 2: Healthcare CMO Segmentation
Figure 3: Global Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 4: Global Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 5: Global Healthcare CMO Market by Type; 2023 (Percentage, %)
Figure 6: Global Healthcare CMO Market by Region; 2023 (Percentage, %)
Figure 7: Global Pharmaceutical CMO Market by Value; 2019-2023 (US$ Billion)
Figure 8: Global Pharmaceutical CMO Market by Value; 2024-2029 (US$ Billion)
Figure 9: Global Pharmaceutical CMO Market by Service; 2023 (Percentage, %)
Figure 10: Global Medical Devices CMO Market by Value; 2019-2023 (US$ Billion)
Figure 11: Global Medical Devices CMO Market by Value; 2024-2029 (US$ Billion)
Figure 12: Global Active Pharmaceutical Ingredients (API) CMO Market by Value; 2019-2023 (US$ Billion)
Figure 13: Global Active Pharmaceutical Ingredients (API) CMO Market by Value; 2024-2029 (US$ Billion)
Figure 14: Global Other Pharmaceuticals CMO Market by Value; 2019-2023 (US$ Billion)
Figure 15: Global Other Pharmaceuticals CMO Market by Value; 2024-2029 (US$ Billion)
Figure 16: North America Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 17: North America Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 18: North America Healthcare CMO Market by Region; 2023 (Percentage, %)
Figure 19: The US Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 20: The US Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 21: The US Healthcare CMO Market by Type; 2023 (Percentage, %)
Figure 22: The US Pharmaceutical Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 23: The US Pharmaceutical Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 24: The US Medical Devices Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 25: The US Medical Devices Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 26: Canada Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 27: Canada Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 28: Mexico Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 29: Mexico Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 30: Europe Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 31: Europe Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 32: Europe Healthcare CMO Market by Region; 2023 (Percentage, %)
Figure 33: Germany Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 34: Germany Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 35: The UK Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 36: The UK Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 37: France Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 38: France Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 39: Italy Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 40: Italy Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 41: Spain Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 42: Spain Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 43: Rest of Europe Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 44: Rest of Europe Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 45: Asia Pacific Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 46: Asia Pacific Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 47: Asia Pacific Healthcare CMO Market by Region; 2023 (Percentage, %)
Figure 48: China Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 49: China Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 50: Japan Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 51: Japan Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 52: India Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 53: India Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 54: South Korea Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 55: South Korea Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 56: Rest of Asia Pacific Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 57: Rest of Asia Pacific Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 58: Rest of World Healthcare CMO Market by Value; 2019-2023 (US$ Billion)
Figure 59: Rest of World Healthcare CMO Market by Value; 2024-2029 (US$ Billion)
Figure 60: Global Percentage Of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 61: Health Expenditure per capita by Countries; 2021 and 2022 (US$ per capita)
Figure 62: Number of Individuals with Chronic Medical Conditions in the US; 2015-2050 (Million)
Figure 63: Global Generic Drugs Market Value, 2023-2031 (US$ Billion)
Figure 64: Global Artificial intelligence (AI) in Healthcare Market; 2021-2030 (US$ Billion)
Figure 65: Catalent, Inc. Net Revenue by Segments; 2023 (Percentage, %)
Figure 66: Samsung Biologics Co. Ltd. Revenue by Product Type; 2023 (Percentage, %)
Figure 67: Aurobindo Pharma Limited Revenue by Business Segments; 2023 (Percentage, %)
Figure 68: Boehringher Ingelheim Net Sales by Segments; 2023 (Percentage, %)
Figure 69: Integer Holdings Corporation Net Sales by Segments; 2023 (Percentage, %)
Figure 70: Piramal Pharma Limited Net Revenue by Business; 2023 (Percentage, %)
Figure 71: Lonza Group AG Sales by Segments; 2023 (Percentage, %)
Figure 72: Thermo Fisher Scientific Inc. Revenues by Segments; 2023 (Percentage, %)
Table 1: Contracts Placed with Pharmaceutical CDMOs; 2020
Table 2: Global Healthcare CMO Market Players Financial Comparison; 2023
